Central Serous Chorioretinopathy (CSC) Completed Phase 2 Trials for Aflibercept (DB08885)

Also known as: Central Serous Chorioretinopathy / Central Serous Retinopathy (CSR) / Central Serous Retinopathy / Serous macular detachment

IndicationStatusPhase
DBCOND0050251 (Central Serous Chorioretinopathy (CSC))Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01971190Efficacy and Safety of Intravitreal Aflibercept Injection for Subacute Central Serous ChorioretinopathyTreatment